EPIS B — Episurf Medical AB Income Statement
0.000.00%
Last trade - 00:00- SEK102.91m
- SEK100.71m
- SEK16.10m
Annual income statement for Episurf Medical AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6.9 | 6.9 | 10.6 | 13.1 | 16.1 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 76.3 | 83.9 | 107 | 90.3 | 74 |
| Operating Profit | -69.4 | -77 | -96.7 | -77.2 | -57.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -69.2 | -77.2 | -94.6 | -76 | -58 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -69.2 | -77.3 | -94.9 | -76.1 | -58.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -69.2 | -77.3 | -94.9 | -76.1 | -58.3 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -69.3 | -77.3 | -94.8 | -76 | -58.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.161 | -0.152 | -0.187 | -0.105 | -0.059 |
| Dividends per Share |